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Abstract
Telomerase activity is readily detectable in extracts from human hematopoietic stem and progenitor cells, but appears
unable to maintain telomere length with proliferation in vitro and with age in vivo. We performed a detailed study of the
telomere length by flow FISH analysis in leukocytes from 835 healthy individuals and 60 individuals with reduced
telomerase activity. Healthy individuals showed a broad range in average telomere length in granulocytes and lymphocytes
at any given age. The average telomere length declined with age at a rate that differed between age-specific breakpoints
and between cell types. Gender differences between leukocyte telomere lengths were observed for all cell subsets studied;
interestingly, this trend could already be detected at birth. Heterozygous carriers for mutations in either the telomerase
reverse transcriptase (hTERT) or the telomerase RNA template (hTERC) gene displayed striking and comparable telomere
length deficits. Further, non-carrier relatives of such heterozygous individuals had somewhat shorter leukocyte telomere
lengths than expected; this difference was most profound for granulocytes. Failure to maintain telomere homeostasis as a
result of partial telomerase deficiency is thought to trigger cell senescence or cell death, eventually causing tissue failure
syndromes. Our data are consistent with these statements and suggest that the likelihood of similar processes occurring in
normal individuals increases with age. Our work highlights the essential role of telomerase in the hematopoietic system and
supports the notion that telomerase levels in hematopoietic cells, while limiting and unable to prevent overall telomere
shortening, are nevertheless crucial to maintain telomere homeostasis with age.
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Introduction
At least a few hundred nucleotides of telomere repeats must
‘‘cap’’ each chromosome end in order to suppress DNA damage
signals and avoid the activation of DNA repair pathways [1–3].
Critically short or ‘‘uncapped’’ telomeres may be repaired by the
enzyme telomerase [4] or by recombination [5]. However, the
capacity of these telomere repair processes appears limited in most
human somatic cells [6]. Apoptosis or cellular senescence is
triggered when too many ‘‘uncapped’’ telomeres accumulate [7],
posing a barrier to tumor growth, but also contributing to loss of
cells with age [8].
Despite increasing evidence that telomere homeostasis is
important in human aging, cancer and disease states, detailed
and comparative information regarding the telomere length in
different human cell subtypes of healthy individuals in relation to
their age is surprisingly modest. Apart from being technically
challenging [9] such studies are complicated because at birth and
throughout life, telomere length is highly variable between
chromosomes [10,11], between cells [12,13] and between individ-
uals. Studies of identical twins have shown that individual
differences in average telomere length appear to be largely
genetically determined [14,15].
In most somatic cells the telomere length declines with age and
with cell division in culture, albeit at different rates [13,16]. For
example, in humans and baboons, lymphocytes show a more
pronounced telomere loss with age than granulocytes [14,17].
These two cell types represent the two major branches of the
hematopoietic system, which can be further subdivided into
distinct cell populations based on their phenotype and function.
Within the hematopoietic hierarchy, the most primitive cells,
hematopoietic stem cells (HSC), have the longest telomeres
[18,19]. HSC differentiate to produce progenitor cells of both
the myeloid and lymphoid lineage that proliferate prior to
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most differentiated myeloid cells such as granulocytes are
incapable of further cell divisions.
The precise role of telomerase in hematopoietic stem and
progenitor cells and in lymphocytes remains poorly understood.
Telomerase expression is readily detected in hematopoietic cells
[20–22]; however, this activity appears unable to prevent telomere
loss with age or proliferation. It is often assumed that telomerase is
required to maintain the telomere length in various stem cells.
With the exception of embryonic stem cells and abnormal tumor
(stem) cells this assumption is not supported by data. Studies on the
role of telomeres and telomerase in HSC from healthy individuals
are challenging because HSC are very rare cells that typically
reside in bone marrow. In contrast, the various nucleated blood
cells that are derived from HSC are easily accessible for study. The
average telomere length in granulocytes can be used as a surrogate
marker for the telomere length in HSC [23], if one assumes that
the number of cell divisions between HSC and granulocytes is
relatively constant [18]. Individual carriers of heterozygous
mutations for either the telomerase RNA gene (hTERC) or the
telomerase reverse transcriptase gene (hTERT) can present with a
wide spectrum of diseases [24] including dyskeratosis congenita
[25,26], bone marrow failure [24] and pulmonary fibrosis [27].
Heritable telomerase deficiencies provide an excellent model to
study the role of telomerase in human hematopoietic cells.
Here we report our data on the median telomere length (MTL)
in five distinct leukocyte subpopulations of over 800 healthy
individuals between birth and 100 years of age as well as 60
individuals that are heterozygous for one of the telomerase genes,
hTERC or hTERT. The telomere length in leukocytes from healthy
individuals was found to vary over a broad range at any given age
and the rate of telomere attrition also varied with age and with cell
type. Strikingly, the telomeres in cells from individuals with
telomerase deficiency were found to be very short in all cell types,
and this deficit was found to be comparable for most cell subtypes
for hTERC or hTERT deficiency. The largest (age adjusted)
differences in telomere length deficits between hTERC or hTERT
were seen in ‘‘naı ¨ve’’ T cells for hTERC deficient individuals and in
NK/differentiated T cells for hTERT deficient individuals. These
results demonstrate that normal telomerase levels are essential to
maintain normal telomere homeostasis in HSC and lymphocytes.
Our results provide valuable reference data for further studies of
telomere biology in health and disease and point to a crucial rate-
limiting role for telomerase in HSC and immune cells.
Results
Lymphocyte and granulocyte telomere length dynamics
with age
We measured the telomere length in lymphocytes and
granulocytes of 835 healthy individuals using automated multi-
color flow FISH (Figure 1). On average, 7 to 8 individuals were
tested for each age-year. Various best-fit models were tested to
model the overall decline in telomere length with age. In view of
the very rapid decline in telomere length in the first years of life in
humans [14] as well as non-human primates [28], we divided the
telomere length decline over three age segments. The first is
between birth and one year of age when the growth rate of bones
and weight in infants shows a marked deceleration (for reference
curves, see http://www.cdc.gov/growthcharts/clinical_charts.
htm). A second arbitrary cut-off was set at 18 years of age because
the decline in telomere length in all leukocytes appeared to drop
notably after puberty. Telomere length data within the three
selected age segments: below 1 year (yr), 1–18 yrs and 19 yr and
higher are shown in Figure 1 and Table 1. The overall age-related
telomere length decline was most pronounced in lymphocytes with
significant losses ranging from 1190 base pairs (bp) per year
between birth and 1 year of age to 126 bp per year during
childhood and 43 bp per year in adulthood. In contrast, the age-
related telomere length decline in granulocytes and by extension in
HSC was more modest during early life (485 bp per year),
childhood (74 bp per year) and adulthood (28 bp per year).
The decline in telomere length with age varies between
leukocyte subpopulations
Telomere length measurements versus age in granulocytes and
lymphocyte subpopulations were used to determine the regression
lines for telomere attrition in the three selected age ranges
(regression estimates shown in Figure 2A; the complete data set
can be accessed in Table S1). These regression lines were shifted
according to data distribution (from the overall regression
estimate) to represent the 99
th,9 0
th,1 0
th and 1
st percentile of
the telomere length distribution in each age segment for each
blood cell subset in healthy individuals. The rate of telomere
length decline varied amongst the different lymphocyte subsets
analyzed. The telomere length decline with age in B lymphocyte
subset (CD45RA+ CD20+) was comparable to that in granulo-
cytes. Memory T (CD45RA2CD202) and mature NK/T
(CD45RA+CD57+) lymphocyte subsets showed the sharpest
decline in telomere length with age, particularly during childhood
with slopes of 2144 and 2155 bp per year respectively. The
CD45RA+CD202 T lymphocyte subset enriched for ‘‘naı ¨ve’’ T
cells and the CD45RA+CD57+ mature NK/T lymphocyte subset
displayed the widest distributions, 2.80 and 2.89 kilobase (kb)
respectively between the 10
th and 90
th percentile of the normal
distribution, throughout the age ranges. Unlike other subsets
CD45RA+CD202 T lymphocytes showed only a modest differ-
ence in the telomere attrition rate between childhood and
adulthood: 89 and 51 bp per year respectively. In contrast, the
memory T lymphocyte subset (CD45RA2CD202) displayed the
narrowest range of telomere length distribution (2.28 kb between
the 10
th and 90
th percentile of the normal distribution). Overall,
Author Summary
Human blood cells all originate from a common precursor,
the hematopoietic stem cell. Telomerase, the enzyme
responsible for adding telomere repeats to chromosome
ends, is active in human hematopoietic stem cells but
appears unable to maintain a constant telomere length
with age. We first document the telomere length of
different blood cell subsets from 835 healthy individuals
between birth and 100 years, to delineate the normal rate
of telomere attrition with age. Telomere lengths of blood
cells were found to be slightly longer in women than in
men, from birth and throughout life. We then compared
this reference data to the telomere length in similar blood
cell subsets from individuals with reduced telomerase
activity as a result of a mutation in one of the genes
encoding telomerase and from their direct relatives.
Strikingly short telomeres were found in telomerase-
deficient individuals, consistent with their cellular pathol-
ogy and disease susceptibility, and somewhat shorter
telomeres than expected were found in cells of relatives
with normal telomerase maintenance. Our data can be
used as a reference for blood cell telomere length in
studies of normal and accelerated aging.
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mature NK/T lymphocytes from older individuals.
Comparisons of telomere length in different leukocyte
subsets
From our cross-sectional data, we determined the average
telomere length decline with age for the different leukocyte
subpopulations (Figure 2B). During childhood, granulocytes,
CD45RA+CD202 ‘‘naı ¨ve’’ T lymphocytes and CD20+ B lympho-
cytes all showed a very similar decline in telomere length, whereas
the rate of decline inmemory T cells wasmuchhigher.Paired MTL
values in different blood cell subsets from the same individual
revealed that around one year of age the telomere length values in
memory T lymphocytes drop below those of granulocytes
(Figure 2C). In contrast, telomere length values in B lymphocytes
remained comparable to those in granulocytes over the entire age
range. One caveat in our measurement of telomere length in
‘‘naı ¨ve’’ (CD45RA+CD202) T lymphocytes is that terminally
differentiated effector lymphocytes re-expressing CD45RA are
likely to represent an increased proportion within this cell
population in older individuals. As a consequence, measurements
within the subset of ‘‘naı ¨ve’’ T cells are variably skewed in older
individuals (as illustrated by the direct comparison of MTL between
‘‘naı ¨ve’’ T lymphocytes and other cell subtypes from the same
individual over 4 distinct age groups in Figure S2A and Table S2).
Gender differences in leukocyte telomere length
measurements
Measurements from cord blood samples provided the earliest
opportunity to assess the telomere lengths in cells from healthy
Figure 1. Decline in telomere length with age differs between lymphocytes and granulocytes. The median telomere length in nucleated
blood cells from 835 healthy individuals ranging from birth (umbilical cord blood) to 102 years of age were measured by flow FISH. The results were
used to calculate the telomere attrition over time using linear regression in three age segments. A. Median telomere length in lymphocytes (black
dots). B. Median telomere length in granulocytes (grey dots). Breakpoints in the piece-wise linear regression lines are marked by rectangles and the
three age groups are marked by dotted vertical grey lines at 1 and 18 years. On average 8 individuals were tested per age-year. C. At any given age, a
wide range of telomere length was observed and the decline in telomere length with age in lymphocytes was more pronounced than in
granulocytes. The shaded area represents the estimated length of subtelomeric DNA. Note that in older individuals, on average only 1–2 kb of
telomere repeats were present in lymphocytes.
doi:10.1371/journal.pgen.1002696.g001
Table 1. Telomere length distribution and age-related telomere length decline in healthy individuals.
lymphocytes granulocytes CD20+ CD45RA+ CD202 CD45RA2 CD57+
Slope (bp/yr) age range: ,1 21190 2485 2916 2947 22073 22818
1–18 2126 274 270 289 2144 2155
19–102 243 228 227 251 232 239
MTL regression (kb) age: birth 11.2 10.3 10.9 11.1 11.4 12.4
1 10.0 9.9 9.9 10.1 9.3 9.6
18 7.9 8.6 8.8 8.6 6.8 7.0
102 4.3 6.2 6.5 4.3 4.1 3.7
MTL range (kb) 1–99 percent 4.34 4.83 4.67 5.02 4.09 5.19
10–90 percent 2.45 2.67 2.37 2.80 2.28 2.89
Telomere length loss between the three selected age segments, results of the piece wise linear regression analysis for each age as depicted in Figure 1, Figure 2, and
Figure 4 as well as telomere length ranges are summarized for each leukocyte subsets.
MTL median telomere length.
doi:10.1371/journal.pgen.1002696.t001
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blood, granulocytes showed the shortest telomeres at birth:
differences were significant for granulocytes versus
CD452CD202 memory T lymphocytes and CD45+CD202
‘‘naı ¨ve’’ T lymphocytes but not for granulocytes versus B
lymphocytes. Comparisons were tested by one-way ANOVA
(n=58): F(5,265)=5.7; P=0.0002, Table S3, followed by Tukey’s
multiple comparison test, see details in Table S4). Interestingly,
female newborns appeared to have longer telomeres than males
(Figure 3A); however this trend did not reach statistical
significance. Further comparisons of telomere length in leukocyte
subsets as a function of gender showed highly significant
differences between males and females in the CD45RA+CD202
‘‘naı ¨ve’’ T lymphocyte subset over the entire age range
(F(4,825)=9.05; P=3.7610
27, ANOVA test result comparing
regression fits; Figure 3B and Table S5). Significant differences
were also seen for other leukocyte subsets in each age segment with
the exception of granulocytes and memory T lymphocytes, which
displayed similar, average telomere lengths after 18 years of age
(Figure S3 and Table S5).
Telomerase is essential to maintain leukocyte telomere
length homeostasis
To study the role of telomerase in hematopoietic cells, we
analyzed the telomere length in leukocyte subpopulations of
individuals carrying a mutation in either hTERT or hTERC
(n=60) in comparison to non-carrier relatives (n=37). The
results, plotted on the telomere length versus age distribution
curves derived from healthy individuals (Figure 2A) are shown in
Figure 4 and Table 1. Strikingly, telomerase heterozygous
individuals showed very short telomeres (typically below the 1
st
percentile of the normal distribution) at all ages and for all blood
cell subsets tested (ANOVA test P,2.2610
216, for full details of
analyses see Table S5). The shortest telomeres were measured in
mature NK/T cells (mean of 3.760.7 kb for all telomerase
heterozygous individuals not adjusted for age, Figure 4A) and the
CD45RA+CD202 ‘‘naive’’ lymphocyte subset appeared the most
severely impacted by telomerase deficiency with an average
difference to the normal distribution (adjusted for age) of Dtel:
3.2 kb. Differential analysis of leukocyte telomere lengths in
leukocytes from hTERT vs. hTERC heterozygous individuals
showed a similar effect on most blood cell subtypes (Figure 4B
and Table 2). Exceptions were an increased telomere loss in the
CD45RA+CD57+ mature NK/T cells (difference of 0.4 Kb) of
hTERT deficient individuals (n=37) and a slightly increased effect
(difference of 0.2 Kb) on the CD45RA+CD202 ‘‘naive’’ lympho-
cyte subset for hTERC deficient individuals (n=23).
Non-carrier relatives of telomerase deficient individuals (hTERT
and hTERC considered together), despite having intact telomerase
genes, also showed somewhat shorter median telomere lengths in
all leukocytes compared to the control population. The largest
difference was measured in the granulocyte subset of non-carrier
Figure 2. Cell type–specific differences in the range and attrition rate of leukocyte telomere length. A. Cross-sectional median telomere
length in nucleated cell types determined by flow FISH in 835 healthy individuals over the age range from birth to 102 years of age. The following
nucleated blood cell subtypes were analyzed : lymphocytes, granulocytes, CD45RA positive CD20 positive B lymphocytes (CD20+), CD45RA positive
CD20 negative lymphocytes (CD45RA+pos CD202) ‘‘naı ¨ve’’ T cells, CD45RA negative CD20 negative lymphocytes (CD45RA2) memory T cells and
CD45RA positive CD57 positive mature NK/T cells (CD57+). Data were analyzed using a piece-wise linear regression model in the age categories 0,
1 yr; 18 yrs and 102 years and for calculation and representation of the telomere length distribution range at any given age (expressed as a
percentile): 99
th (red), 90
th (dashed green top), 50
th (green), 10
th (dashed green bottom) and 1
st (blue). Some of the healthy subjects (n=835) did not
have sufficient cells for analysis of one or more of the cell subsets. B. Piece-wise linear regression analysis overlay representing the modeled estimate
of telomere length per age for: B lymphocytes (grey), granulocytes (black dashed), ‘‘naı ¨ve’’ T lymphocytes (black), memory T lymphocytes (black
interrupted dashed) and mature NK/T lymphocytes (grey dashed). Regression breakpoints were set at age 1 and age 18 years. C. Paired comparison of
telomere length in granulocytes and memory T lymphocytes from the same individuals. Age groups were as follows: cord blood samples and below
age 1 (n=60, red), age 1 to 18 (n=171, black), 19 and above 19 (n=604, green).
doi:10.1371/journal.pgen.1002696.g002
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indicative of HSC deficit and warrants further investigation
(Figure 4A; ANOVA test: F(3,837)=8.1; P=2.63610
25, for full
details of analyses see Table S5). Both parents and siblings of
heterozygous individuals were found to have slightly shorter
telomere lengths for age (Table 2 and Figure S4). Differential
analysis of parents (n=6) and siblings (n=4) of hTERT deficient
individuals was also performed and showed comparable telomere
length deficits for all cell subsets tested (Figure S4 and data not
shown) in this relatively small group.
Discussion
In this report, we show telomere length data for five distinct
leukocyte subpopulations from over 800 healthy individuals,
representing a comprehensive and representative cross-sectional
analysis of telomere length in leukocyte subpopulations over the
entire human life span. The value of this data is illustrated by our
analysis of individuals with heritable telomerase deficiencies.
Leukocyte telomere length was found to clearly distinguish
between relatives with and without mutations in hTERT or hTERC
supporting telomere length measurements as a screen for
mutations in ‘‘telomere maintenance’’ genes. Our results confirm
and extend earlier reports of telomere loss in leukocytes with age
[13,14] and document a crucial role for telomerase in controlling
leukocyte telomere length.
Telomerase expression is readily detected in most hematopoietic
cells [20–22], yet this activity appears unable to prevent the overall
loss of telomeric DNA with age or proliferation. Most likely,
telomerase is primarily required to directly act on chromosome
ends in hematopoietic cells themselves, however secondary,
indirect effects of telomerase via cells that support cell proliferation
[29] or possible effects of the TERT protein on transcription in
stem cells [30] are difficult to exclude.
Heterozygosity for one of the telomerase genes, expected to
reduce telomerase levels by half, results in a striking telomere deficit
(Figure 4).Howcanthisfindingbe explained? One possibilityis that
the primary function of telomerase in somatic cells is the repair [8]
or protection [31] of critically short telomeres. Failure to properly
‘‘cap’’ all chromosome ends with telomere repeats results in
activation of a DNA damage response [1,32]. Detrimental
consequences for HSCs and lymphocytes could result when DNA
damage signals from uncapped telomeres persist or reach a certain
threshold and cause apoptosis of such cells. Impaired ‘‘capping’’ of
telomeres in cells with reduced telomerase could affect telomere
length directly and indirectly. Direct effects on telomere length
could result from normal replication of telomeric DNA [8] and
damage caused by reactive oxygen species [33–35]. Indirect effect
on telomere length would result from the additional cell division
required to compensate for the increased cell losses. Compensatory
cell divisions in cells from telomerase deficient individuals could be
particularly taxing as more short telomeres are expected to emerge
with each extra cell division. The resulting feed-forward loop could
exhaust the stem cell compartment in infants and children
explaining the marrow failure typically seen in pediatric telomerase
deficient patients. In cases where sufficient stem cells survived till
adulthood, the same unproductive feed-forward loop could exhaust
cells of the immune system. This possibility is in line with the
observation that after puberty telomere attrition in more mature
subsets of T and NK cells is notably higher than in granulocytes as a
surrogate marker for stem cells (Figure 2). We speculate that the
balance betweenendcellssuchasgranulocytesandmacrophageson
the one hand and various other immune cell types on the other is
perturbed in older telomerase deficient patients. Such an imbalance
Figure 3. Gender differences in leukocyte telomere length. A. Telomere length measurements in leukocyte subsets from female (pink) versus
male (blue) healthy newborns (n=58; females n=29, males n=29). The following white blood cell subsets were tested lymphocytes, granulocytes,
‘‘naı ¨ve’’ T lymphocytes (CD45RA+CD202), memory T lymphocytes (CD45RA2CD202) and B lymphocytes (CD20+). Each dot represents an individual
sample, mean (horizontal bar) and standard deviation (vertical bar) for each cell type are shown. All subsets display a trend for longer average
telomere lengths in females; however this trend does not reach statistical significance (Student’s t test, data not shown). B. Piece-wise linear
regression analysis representing the calculated telomere length per age for females (pink) versus males (blue) ‘‘naı ¨ve’’ T lymphocytes
(CD45RA+CD202). Breakpoints were at 1 year of age and at 18 years. Analysis of variance for females versus males (statistical model in R) showed
significance (F(4,825)=9.05; P=3.7610
27, ANOVA test result comparing regression fits). For data on other subsets and details of statistical analysis,
see Figure S3 and Table S5.
doi:10.1371/journal.pgen.1002696.g003
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PLoS Genetics | www.plosgenetics.org 5 May 2012 | Volume 8 | Issue 5 | e1002696Figure 4. Telomerase is essential to maintain telomere length in leukocytes. The telomere length distribution in healthy individuals
(Figure 2) was used to plot the median telomere length values of leukocyte subsets obtained with: A. leukocytes from 60 telomerase deficient
patients (red) and 37 non-carrier relatives (black). B. leukocytes from 37 hTERT mutation heterozygous individuals (red) and 23 hTERC mutation
heterozygous carriers (black).
doi:10.1371/journal.pgen.1002696.g004
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create pro-fibroticconditions or result infailureto remove senescent
cells [36].
Apart from cell turnover and telomerase levels, the telomere
length in parental chromosomes at fertilization is another probable
variable in the disease manifestations of telomerase deficient
patients. This variable will determine when critically short
telomeres, requiring repair or capping by telomerase, will appear:
during development or during adult life. This notion is in line with
the age-related onset of symptoms or ‘‘anticipation’’ in multi-
generation telomerase deficiency disorders [24,37] and our
observation that telomeres in cells from unaffected children and
parents of telomerase heterozygous individuals are somewhat
shorter than expected (Figure 4 and Table 2).
As was shown previously for human lymphocytes and granu-
locytes [14,38] and confirmed in longitudinal studies of non-
human primates [28], leukocyte telomere length shortens most
dramatically very early in life. This rapid decline can be explained
by steady proliferation of stem cells and immune cells after birth.
After one year of age we observed a rapid deceleration in telomere
loss most likely reflecting an intrinsic, ontogeny-related change in
stem cell turnover and function [39], which has also been observed
in postnatal mice [40,41]. Our observations with human and
primate cells suggest that each HSC cell division in these species is
‘‘counted’’ by the loss of telomeric DNA. Why a relative modest
decline in telomerase activity in humans results in a wide spectrum
of diseases whereas complete loss of telomerase is typically
tolerated for several generations in yeast, plants, worms and mice
remains incompletely understood [42].
The shortest overall telomere lengths were measured in the
mature NK/T cell subsets of older healthy individuals and of
hTERT telomerase-deficient individuals. These results suggest that
one of the primary consequences of telomere attrition and
telomerase deficiencies could be the loss of NK immune function.
This notion is compatible with the reported age-related decline in
the number and function of these cells [43]. Of note, in some
individuals the estimated telomere length in mature NK/T cells
was near the predicted minimal telomere length (represented as a
shaded area in Figure 1 and Figure 2) meaning that on average
each chromosome end in those cells has fewer than 1 kb of
telomere repeats.
Despite the finding that at birth telomeres in lymphocytes are
longer than in granulocytes and despite the selective expression of
telomerase in cells of the lymphoid lineage upon activation
[22,44], T lymphocytes displayed a sharp decline in telomere
length with age. The steady decline in the telomere length in T
cells likely contributes to compromised adaptive immunity in the
elderly [45] and in individuals with telomerase deficiencies [46].
Interestingly, the narrowest telomere length distribution in
leukocyte subsets from healthy individuals was observed in the
memory T cell compartment, pointing to a possible role of
telomere length in shaping the T cell repertoire and immune
memory.
Our study of gender specific differences in telomere length
confirmed previous observations that telomere lengths on average
appear to be somewhat longer in females than in males [47]. The
fact that this trend is already seen at birth raises questions that
warrant further investigation: do females have fewer HSC at birth?
Do female HSC have a higher replicative potential because of
longer telomeres? Do stem cells in females have higher telomerase
activity, possibly influenced by levels of sex hormones [48] or do
other factors explain the longer telomeres in female leukocytes?
Epidemiological studies have been conducted to examine the
potential validity of using relative leukocyte telomere length as a
disease or aging associated biomarker. Interest in this area has
greatly increased following recent reports of associations of shorter
leukocyte telomere lengths with morbidity (such as cardiovascular
disease or diabetes reviewed in [49]) and in response to external
factors such as chronic stress [50]. More data is needed to confirm
these findings and establish whether shorter leukocyte telomere
lengths are associated with overall increased mortality in older
adults [51,52] and whether the increased risk of infection such as
pneumonia in elderly individuals differs significantly in relation to
their telomere lengths.
In conclusion, the data presented here contribute valuable base-
line information regarding the telomere length in subpopulations
of leukocytes during normal human ageing. This information will
be a useful reference in studies of a variety of health conditions.
Our data show that suppression of half of telomerase levels over a
lifetime can severely compromise the telomere homeostasis of
granulocytes as a surrogate marker for HSCs, and of immune cells.
This likely is a dominant factor in the serious impairment of cell
function and proliferative capacity that has been documented in
telomerase deficient individuals. It seems possible that more
effective short-term inhibition of telomerase could compromise the
function of hematopoietic cells more acutely. Most likely,
limitations imposed by progressive telomere loss act as a tumor
suppressor mechanism in long-lived animals [42]. If so, caution is
also needed for strategies that aim to rejuvenate older cells by
reactivation of telomerase. The telomere length data described in
this paper provide reference data for therapeutic strategies that
target telomerase and for further studies on the role of telomeres
Table 2. Telomere loss corrected for age (Dtel) in telomerase heterozygous individuals and unaffected relatives.
Dtel (kb)
1 lymphocytes granulocytes CD20+ CD45RA+ CD202 CD45RA2 CD57+
Tel +/2 individuals (60) 22.7 22.9 22.8 23.2 22.3 22.4
TERT +/2 individuals (37) 22.6 22.9 22.7 23.1 22.3 22.5
TERC +/2 individuals (23) 22.8 22.9 22.9 23.3 22.3 22.1
Tel +/+ relatives (36) 20.6 20.9 20.6 20.7 20.6 20.6
Tel +/+ parent (7) 20.9 20.8 20.8 21.1 20.8 20.6
Tel +/+ sibling (8) 20.7 20.7 20.8 20.9 20.8 20.6
Summary of telomere loss adjusted for age (Dtel) in telomerase heterozygous individuals considered as a group (Tel), considered as TERT or TERC heterozygous
individuals separately, and unaffected relatives of telomerase heterozygous individuals considered as a group (Tel), or separating parents or siblings.
1Difference between the median telomere length and the regression estimate of the telomere length distribution in healthy individuals of the same age (Dtel).
Tel: hTERC or hTERT gene.
doi:10.1371/journal.pgen.1002696.t002
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conditions.
Materials and Methods
Ethical statement
All subjects enrolled in this study in Vancouver signed informed
consent forms that were approved by the University of British
Columbia (BC) and BC Cancer Agency Research Ethics Board.
All samples from patients outside Vancouver were obtained with
informed consent and approval of local ethical review boards in
accordance with the Declaration of Helsinki.
Healthy donors, telomerase-deficient individuals, and
non-carrier relatives
Anonymous cord blood samples were obtained from healthy full
term births with parental informed consent. Since no associate
information was available for these samples, gender testing was
performed by FISH as described below.
Anonymous peripheral blood samples were obtained from 835
healthy individuals between the ages of 6 months to 102 years of
age screened for clotting disorders; samples where no clotting
disorders were found were made available for study; only gender
and age information were provided.
Samples from 60 individuals with confirmed telomerase
deficiencies due to heterozygous mutations for either the
telomerase reverse transcriptase (hTERT) or the RNA template
(hTERC) gene and their 37 (non-carrier) relatives were included in
our analysis and were described previously, (mean ages for both
groups were 41 and 45 years respectively [25,53–59]; all 97
participants or their guardians provided written informed consent
in accordance with the Declaration of Helsinki.
Cord blood gender determination
X and Y chromosome specific FISH was preformed as
previously described [60]. Briefly, nucleated cord blood cells were
fixed with methanol–acetic acid then dropped onto slides. Slides
were fixed with formaldehyde, treated with pepsin, and dehydrat-
ed with ethanol. The hybridization mix containing fluorescently
labeled peptide nucleic acid (PNA) probes specific for centromere
repeats of respectively the X chromosome and the long arm of the
Y chromosome were added to the slides. Following denaturation
of DNA at 80uC for 3 minutes slides were incubated at room
temperature for 30 minutes, washed, counterstained with DAPI
and mounted using DABCO anti-fading reagent (Sigma Aldrich).
Images were acquired and analyzed as previously described [60].
Mutational analysis
hTERT and hTERC genotyping was performed as described
previously [25,53–59].
Telomere length measurements by flow FISH
Telomere length measurements using automated multicolor
flow-fluorescence in situ hybridization (flow FISH) was performed
as described [61]. Briefly, white blood cells (WBCs) were isolated
by osmotic lysis of erythrocytes in whole blood using NH4Cl. The
WBCs were then mixed with bovine thymocytes of known
telomere length (which serve as an internal control), denatured
in formamide at 87uC, and hybridized with a fluorescein-
conjugated (CCCTAA)3 peptide nucleic acid (PNA) probe specific
for telomere repeats and counterstained with LDS751 DNA dye.
The fluorescence intensity in, granulocytes, total lymphocytes and
lymphocyte subsets defined by labeled antibodies specific for
CD20, CD45RA and CD57 relative to internal control cells and
unstained controls was measured on a FACSCalibur instrument
(Becton Dickinson) to calculate the median telomere length from
duplicate measurements. Further details regarding telomere length
measurements and data sets are described in Online Supplemen-
tary Material as well as depicted in Figure S1.
Some of the total 835 healthy subjects did not have sufficient
cells for analyses of one or more of the cell subsets tested:
granulocytes, B lymphocytes, or mature NK/T cells. Specific
improvements were developed during the 8 year of the healthy
donor study allowing for the testing of additional cell subsets (B
and mature NK/T [62]) explaining why fewer measurements are
reported for these subsets. In addition, a slight modification was
made to the cell lysis protocol: from a semi-automated small
volume lysis in a 96 well format [63]) to the current larger volume
individual sample lysis [61]. The data obtained during these two
experimental periods were first analyzed separately to test for
differences between the first and second data sets. Briefly, both
data sets were found to have comparable telomere length
distributions over age, with a small but notable decrease in the
calculated granulocyte telomere length together with a decrease in
the range of granulocyte telomere length values in the second data
set (Figure S1). These differences may be explained by the protocol
improvements in the second set that resulted in a better resolution
of signal and a reduction in the background fluorescence observed
in cell types with large volumes of cytoplasm. Since the ranges
lower limits were similar between the two data sets and since the
majority of the data for both sets falls within the same 10
th to 90
th
percentile range, the two sets were merged and analyzed together
for curve fitting models and reference comparisons.
Statistical analyses
Analyses were performed using Microsoft Excel (Microsoft Office
2007), GraphPad Prism (version 4) and R (version 2.6.1, 2007, The
R Foundation for Statistical Computing); t-Tests were two-tailed
and performed on data with a normal distribution (KS test). Linear
modeling (lm function in the R language) was used to carry out the
regression analysis and estimate the piecewise linear curves with
breakpoints hingedat 1 and 18 years of age. Wefound that this gave
the best fit with the least mean square error and more consistent
error distribution across the age ranges as compared to using a
number of polynomial fits (linear, quadratic, cubic or quartic). The
99
th,9 0
th,1 0
th and 1
st percentile curves were obtained by vertical
shift of the estimated regression curve to span the desired number of
data points in the primary data set of healthy subjects (n=835) that
wererepresentative for this segment of distribution. To compare the
telomere lengths of one population against another, the ANOVA
function inthe R language was employedto test if the data was from
the same or 2 different model fits [64].
Online supplementary material
Figure S1 depicts data from two consecutive experimental
periods separately for lymphocytes and granulocytes respectively,
and displays the previous quadratic curve fitting model (first ,400
data points) compared to the current three piece-wise linear
regression model (for which first and second data sets were
combined) used in Figure 2, Figure 3, and Figure 4.
Figure S2 complements Figure 2 and highlights the telomere
length skewing specifically seen in CD45RA+ CD202 lympho-
cytes of older individuals, where a higher proportion of terminally
differentiated lymphocytes are likely present within the cell
population with this phenotype. Further, Figure S2 depicts the
skewing observed in telomerase heterozygous individuals, compa-
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of age).
Figure S3 complements Figure 3 and depicts gender segregated
telomere length data measured by flow FISH for all leukocyte cell
subsets tested, together with the model fit statistical test results
from these analyses.
Figure S4 complements Figure 4 and depicts further analysis of
leukocyte telomere length data from direct relatives, siblings or
parents of telomerase heterozygous individuals. From this
relatively small group, although a trend towards shorter MTLs is
observed, no statistical difference between the groups and no
statistically significant difference compared to healthy individuals
was detected (Table S5).
Table S1 displays the complete telomere length data sets.
Duplicate leukocyte telomere length data were collected over an
eight year period and analyzed on two occasions (first analysis after
391 samples and the present analysis after next 445 samples). For the
first set of data, freshly isolated nucleated blood cells were used
whereas for the second set, nucleated cells were frozen prior to flow
FISH (see Materials and Methods and data set comparisons, Figure
S1). No marked differences in the calculated telomere length between
the two data sets were observed for lymphocytes or lymphocyte
subsets.Althoughthegranulocytetelomerelengthvalueswereslightly
lower and more narrowly distributed in the second data set, the
overall results were pooled for the current analysis.
Table S2 displays telomere length cell subset correlations at
different age ranges. This table complements Figure 2 and Figure
S2. It displays the correlative r values between paired cell
population telomere length values. The cell population chosen as
a reference has a set value of 1.
Tables S3, S4 and S5 display the complete statistical ANOVA
analysis results for comparing telomere lengths of leukocyte subsets
in cord blood (at birth), and comparing the two linear models (an
estimate of the entire population) and an estimate of where factor
‘‘X’’ (gender for example) was taken into consideration and
showed a significant difference.
Supporting Information
Figure S1 Comparison between leukocyte telomere length data
sets and between statistical models over the study period. A. In the
first study period, median lymphocyte and granulocyte telomere
length measurements determined by flow FISH in 391 healthy
individuals from birth (umbilical cord blood) to 102 years of age
(blue dots) with reference curves derived from a quadratic function
which provided a better fit than linear regression models over the
entire age-range. Quadratic model distribution curves represent the
projected modeled percentiles of the data: 99th (red), 90th (green
top), 50th (green centre), 10th (green bottom) and 1st (blue)
percentile of telomere range distribution per age. B. Median
lymphocyte and granulocyte telomere length measurements in 391
consecutive individuals after 96 well format red cell lysis (Data set 1,
blue dots) and 444 other individuals (Data set 2, black dots) after
large volume red cell lysis. C. In the combined data set, median
lymphocyte and granulocyte telomere length measurements from
the combined data sets with piece-wise linear model percentile
estimates: 99th (red), 90th (dashed green top), 50th (green centre),
10th (dashed green bottom) and 1st (blue) percentile of the telomere
range distribution at any given age. Three linear regression
segments were connected at respectively one year and eighteen
years of age, to give better representation of the data at younger and
older age ranges; insets represent magnifications of the predicted
telomere length distribution between birth and five years of age.
(EPS)
Figure S2 Comparison of median telomere length (MTL) in
CD45RA+CD202 ‘‘Naı ¨ve’’ T lymphocytes and other nucleated
blood cell types from the same individual over four distinct age
groups. This table complements Figure 2 and Figure S2A. It
displays the correlative r values between paired cell population
telomere length values. Age-related changes in the relationship
between the telomere length (in kb) in ‘‘naı ¨ve’’ T lymphocytes and
the indicated cell types (granulocytes, memory T lymphocytes
(CD45RA2CD202) or B lymphocytes (CD45RA+CD20+). The
cell population chosen as a reference has a set value of 1. Each
point represents paired measurements for the two leukocyte
subsets within the same healthy individual; individuals are coded
within age group as follows: cord blood samples and below one
year of age (n=60, red), between one and eighteen years of age
(n=171, black), adults between nineteen and seventy five years of
age (n=431, green) and elderly, over seventy five years of age
(n=173, orange). Paired measurements are represented for: A.
healthy individuals and B. telomerase heterozygous individuals.
(EPS)
Figure S3 Gender differences in telomere length between
leukocyte subpopulations. Median telomere length values in
leukocyte subpopulations from 835 healthy females and males
ranging from newborns (umbilical cord blood) to hundred years of
age determined by flow FISH. The following white blood cell
subtypes were tested: lymphocytes, granulocytes, B lymphocytes
(CD20+), ‘‘naı ¨ve’’ T lymphocytes (CD45RA2pos CD20+),
memory T lymphocytes (CD45RA2) and mature NK/T cells
(CD57+). Curves representing the 50th percentile curve of the
modeled median telomere length per age for females (red) versus
males (blue) are shown. Three linear segments connected at one
year and eighteen years of age were used. ANOVA test P values
for the difference between females and males for each gender
specific subset were: lymphocytes P=1.5661025, granulocytes
P=0.37, B lymphocytes P=0.0018, ‘‘naı ¨ve’’ T lymphocytes
P=3.761027, memory T lymphocytes P=0.0012, mature
NK/T cells P=0.0028 respectively. (for complete analysis details,
see Table S5).
(EPS)
Figure S4 Leukocyte telomere lengths of non-carrier siblings or
parents of telomerase deficient individuals. The telomere length
distribution in healthy individuals (Figure 2) was used to plot the
median telomere length values obtained with cells from: leukocytes
from 8 non-carrier siblings (cyan), 7 non-carrier parents (orange) of
telomerase-deficient patients and 21 direct relatives of idiopathic
pulmonary fibrosis telomerase-deficient patients (sibling or parent
status unknown).
(EPS)
Table S1 Complete telomere length data sets from healthy
individuals. Leukocyte median telomere length data (MTL, kb)
were collected over an eight year period and analyzed on two
occasions (first analysis after 391 samples and the present analysis
after another 445 samples). For the first set of data, freshly isolated
nucleated blood cells were used whereas for the second set,
nucleated cells were frozen prior to flow FISH (see Online
Supplementary Material on flow FISH method for details and
Figure S1 for data set comparisons). No marked differences in the
calculated telomere length between the two data sets were
observed for lymphocytes or lymphocyte subsets (not shown).
Although the granulocyte telomere length values were slightly
lower and more narrowly distributed in the second data set, the
overall results were pooled for the current analysis.
(XLS)
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age ranges. This table complements Figure 2 and Figure S2. It
displays the correlative r values between paired cell population
telomere length values. The cell population chosen as a reference
has a set value of 1.
(DOC)
Table S3 ANOVA results summary table on the effect of gender
on cord blood telomere length measurements. Effect of gender test
of cord blood samples, in reference to Figure 3A; One way
ANOVA with Tukey’s multiple comparison test (Table S4).
(DOC)
Table S4 ANOVA post test results summary table on the effect
of gender on cord blood telomere length measurements. One way
ANOVA with Tukey’s multiple comparison test results of the
effect of gender on cord blood telomere length measurements.
(DOC)
Table S5 ANOVA results summary table on the effects of
gender on telomere length measurements. This table summarizes
the results comparing the two linear models (an estimate of the
entire population) and an estimate of where factor ‘‘X’’ (gender for
example) was taken into consideration and showed a significant
difference. The following factors were tested: effect of gender (total
population); effect of telomerase deficiency; effect for relatives of
telomerase deficient individuals; effect of gene affected TERT or
TERC for heterozygous individuals or relatives; effect of family
relationship to heterozygous individual (sibling or parent). A linear
model was applied to fit the telomere length variation with age to a
piece-wise linear function with two age breakpoints (age 1and age
18). An ANOVA (F-test) of the model fit against a model that also
takes into consideration the gender of the individual and was
applied and showed that there was a significant difference in
gender on telomere length (P=3.7e-07). The ANOVA compares
the two linear models (an estimate of the entire population (one
linear fit) and an estimate where gender (or another factor) was
taken into consideration (two linear fits to the data)) and showed a
significance difference (i.e 2 fits are better than 1 fit, or differences
in gender; which can be extended to say a difference in female
gender or just as equally male gender.) With reference to the
ANOVA tables, the first line shows the Residual degree of freedom
(Res.Df) and Residual sum of squares (RSS) for the first model (no
difference in gender). The second line (difference in gender model)
shows in addition, the degree of freedom for the model, sum of
squares, the F-value and the probability of the F-statistics (Pr (.F).
If this value is less than 0.05, then there is a good chance that
gender (for example) has an effect on telomere length.
(DOC)
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